Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by DryBoneson Apr 27, 2018 3:47am
106 Views
Post# 27948571

RE:RE:RE:At 48 years old I’ve seem some scams in my day...

RE:RE:RE:At 48 years old I’ve seem some scams in my day...You are correct Bio, (or is that biohazard,   perhaps it's bio-haphazard) but it was Telesta that set the 40% standard in consultation with the FDA.  Telesta was convinced and convinced their partners that they coud meet that.  As a consequence they ended up with sht on their faces.  If they had said 20 % from the beginning and met an objective standard in number of cohorts then FDA would have been more amenable to approval or conditional approval in useage with other bladder cancer treatmets.  So here we have PLI claiming a 100%  success rate, on what, 10 subjects?

So to presume or equate science, or weak science as good business practise shows how ignorant and stupid you are regarding investing. You want to shift the discussion to your own misconceptions as  informed.  You are not in the least bit informed.  You are a two-bit nobody pretending you understand the science. .  You are nothing but a wannabe investor who lays down before management and says fukme, and when they fail you lay down again and say fukme again.  We need a little shareholder activism here, not mindless, zombie, lobotomised, half-wit dogmatic followers like you.  Let's get some real management, not a bunch of failures.


Bullboard Posts